Literature DB >> 10623657

Early increase in cyclin-D1 expression and accelerated entry of mouse hepatocytes into S phase after administration of the mitogen 1, 4-Bis[2-(3,5-Dichloropyridyloxy)] benzene.

G M Ledda-Columbano1, M Pibiri, R Loi, A Perra, H Shinozuka, A Columbano.   

Abstract

We have previously demonstrated that hepatocyte proliferation induced by the mitogen 1,4-bis[2-(3,5-dichloropyridyloxy)] benzene (TCPOBOP) is independent of changes in cytokines, immediate early genes, and transcription factors that are considered to be necessary for regeneration of the liver after partial hepatectomy (PH) or necrosis. To further investigate the differences between mitogen-induced mouse hepatocyte proliferation and liver regeneration after PH, we have measured the expression of cyclin D1, cyclin D3, cyclin E, and cyclin A and of the cyclin-dependent kinases CDK2, CDK4, and CDK6. The involvement of the cyclin-dependent kinase inhibitors p21 and p27 and of the oncosuppressor gene p53 was also examined at different times after stimulation of hepatocyte proliferation. Results showed that a single administration of TCPOBOP caused a very rapid increase in the levels of cyclin D1, a G1 protein, when compared with two thirds PH (8 hours versus 30 hours). The early increase in cyclin D1 protein levels was associated with a faster onset of increased expression of S-phase-associated cyclin A (24 hours versus 36 hours with PH mice). Accordingly, measurement of bromodeoxyuridine (BrdU) incorporation revealed that, although approximately 8% of hepatocytes were BrdU-positive as early as 24 hours after TCPOBOP, no significant changes in BrdU incorporation were observed at the same time point after two thirds PH. The expression of other proteins involved in cell cycle control, such as cyclin-dependent kinases (CDK4, CDK2, CDK6), was also analyzed. Results showed that expression of CDK2 was induced much more rapidly in TCPOBOP-treated mice (2 hours) than in mice subjected to PH (36 hours). A different pattern of expression in the two models of hepatocyte proliferation, although less dramatic, was also observed for CDK4 and CDK6. Expression of the CDK inhibitors p21 and p27 and the oncosuppressor gene p53 variably increased after two thirds PH, whereas basically no change in protein levels was found in TCPOBOP-treated mice. The results demonstrate that profound differences in many cell cycle-regulatory proteins exist between direct hyperplasia and compensatory regeneration. Cyclin D1 induction is one of the earlier events in hepatocyte proliferation induced by the primary mitogen TCPOBOP and suggests that a direct effect of the mitogen on this cyclin may be responsible for the rapid onset of DNA synthesis observed in TCPOBOP-induced hyperplasia.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10623657      PMCID: PMC1868640          DOI: 10.1016/S0002-9440(10)64709-8

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  53 in total

Review 1.  Liver regeneration versus direct hyperplasia.

Authors:  A Columbano; H Shinozuka
Journal:  FASEB J       Date:  1996-08       Impact factor: 5.191

Review 2.  Cell cycle control in mammalian cells: role of cyclins, cyclin dependent kinases (CDKs), growth suppressor genes and cyclin-dependent kinase inhibitors (CKIs).

Authors:  X Graña; E P Reddy
Journal:  Oncogene       Date:  1995-07-20       Impact factor: 9.867

Review 3.  Inhibitors of mammalian G1 cyclin-dependent kinases.

Authors:  C J Sherr; J M Roberts
Journal:  Genes Dev       Date:  1995-05-15       Impact factor: 11.361

4.  MyoD-induced expression of p21 inhibits cyclin-dependent kinase activity upon myocyte terminal differentiation.

Authors:  K Guo; J Wang; V Andrés; R C Smith; K Walsh
Journal:  Mol Cell Biol       Date:  1995-07       Impact factor: 4.272

5.  p53-dependent and independent expression of p21 during cell growth, differentiation, and DNA damage.

Authors:  K F Macleod; N Sherry; G Hannon; D Beach; T Tokino; K Kinzler; B Vogelstein; T Jacks
Journal:  Genes Dev       Date:  1995-04-15       Impact factor: 11.361

Review 6.  Liver regeneration. 2. Role of growth factors and cytokines in hepatic regeneration.

Authors:  N Fausto; A D Laird; E M Webber
Journal:  FASEB J       Date:  1995-12       Impact factor: 5.191

7.  Exit from G0 and entry into the cell cycle of cells expressing p21Sdi1 antisense RNA.

Authors:  M Nakanishi; G R Adami; R S Robetorye; A Noda; S F Venable; D Dimitrov; O M Pereira-Smith; J R Smith
Journal:  Proc Natl Acad Sci U S A       Date:  1995-05-09       Impact factor: 11.205

8.  Targeted in vivo expression of the cyclin-dependent kinase inhibitor p21 halts hepatocyte cell-cycle progression, postnatal liver development and regeneration.

Authors:  H Wu; M Wade; L Krall; J Grisham; Y Xiong; T Van Dyke
Journal:  Genes Dev       Date:  1996-02-01       Impact factor: 11.361

9.  Mice lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control.

Authors:  C Deng; P Zhang; J W Harper; S J Elledge; P Leder
Journal:  Cell       Date:  1995-08-25       Impact factor: 41.582

10.  p21-containing cyclin kinases exist in both active and inactive states.

Authors:  H Zhang; G J Hannon; D Beach
Journal:  Genes Dev       Date:  1994-08-01       Impact factor: 11.361

View more
  21 in total

1.  Excessive hepatomegaly of mice with hepatocyte-targeted elimination of integrin linked kinase following treatment with 1,4-bis [2-(3,5-dichaloropyridyloxy)] benzene.

Authors:  Shashikiran Donthamsetty; Vishakha S Bhave; Corrine S Kliment; William C Bowen; Wendy M Mars; Aaron W Bell; Rachel E Stewart; Anne Orr; Chuanyue Wu; George K Michalopoulos
Journal:  Hepatology       Date:  2011-01-06       Impact factor: 17.425

Review 2.  Molecular regulation of hepatocyte generation in adult animals.

Authors:  Joe W Grisham; William B Coleman
Journal:  Am J Pathol       Date:  2002-10       Impact factor: 4.307

3.  Nuclear receptors CAR and PXR in the regulation of hepatic metabolism.

Authors:  E S Tien; M Negishi
Journal:  Xenobiotica       Date:  2006 Oct-Nov       Impact factor: 1.908

4.  The Thyromimetic KB2115 (Eprotirome) Induces Rat Hepatocyte Proliferation.

Authors:  Marta Szydlowska; Monica Pibiri; Andrea Perra; Elisabetta Puliga; Sandra Mattu; Giovanna M Ledda-Columbano; Amedeo Columbano; Vera P Leoni
Journal:  Gene Expr       Date:  2017-04-13

5.  Activation of CAR and PXR by Dietary, Environmental and Occupational Chemicals Alters Drug Metabolism, Intermediary Metabolism, and Cell Proliferation.

Authors:  J P Hernandez; L C Mota; W S Baldwin
Journal:  Curr Pharmacogenomics Person Med       Date:  2009-06-01

6.  TCPOBOP-Induced Hepatomegaly and Hepatocyte Proliferation are Attenuated by Combined Disruption of MET and EGFR Signaling.

Authors:  Bharat Bhushan; John W Stoops; Wendy M Mars; Anne Orr; William C Bowen; Shirish Paranjpe; George K Michalopoulos
Journal:  Hepatology       Date:  2018-12-31       Impact factor: 17.425

7.  1,4-Bis[2-(3,5-dichloropyridyloxy)]benzene induces substantial hyperplasia in fibrotic mouse liver.

Authors:  Edina Bugyik; Katalin Dezso; Eszter Turányi; Kinga Szurián; Sándor Paku; Peter Nagy
Journal:  Int J Exp Pathol       Date:  2012-01-14       Impact factor: 1.925

8.  Effects on coagulation factor production following primary hepatomitogen-induced direct hyperplasia.

Authors:  Kohei Tatsumi; Kazuo Ohashi; Sanae Taminishi; Soichi Takagi; Rie Utoh; Akira Yoshioka; Midori Shima; Teruo Okano
Journal:  World J Gastroenterol       Date:  2009-11-14       Impact factor: 5.742

9.  Sex-Differential Responses of Tumor Promotion-Associated Genes and Dysregulation of Novel Long Noncoding RNAs in Constitutive Androstane Receptor-Activated Mouse Liver.

Authors:  Nicholas J Lodato; Tisha Melia; Andy Rampersaud; David J Waxman
Journal:  Toxicol Sci       Date:  2017-09-01       Impact factor: 4.849

10.  Triiodothyronine stimulates hepatocyte proliferation in two models of impaired liver regeneration.

Authors:  A Columbano; M Simbula; M Pibiri; A Perra; M Deidda; J Locker; A Pisanu; A Uccheddu; G M Ledda-Columbano
Journal:  Cell Prolif       Date:  2008-04-14       Impact factor: 6.831

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.